Shipping Bottlenecks Could Last Well Into 2022 — Why That’s Good News For Investors Shares of container lines have surged in the 18 months since the pandemic began. 4 MIN READ 11.5.2021
Novo Nordisk To Acquire Prothena’s ATTR Amyloidosis Program for Up to $1.2 Billion ATTR amyloidosis is a life-threatening genetic disease that affects the heart, nerves and other organs. 1 MIN READ 07.12.2021
Mount Sinai Discovers Novel Drug Combo Helps Replicate Insulin-Producing Beta Cells The result is an important step toward a diabetes treatment that restores the body’s ability to produce insulin. 3 MIN READ 02.13.2020
Genentech’s Spinal Muscular Atrophy Therapy Shows Significant Improvement in Motor Function Risdiplam showed medically-meaningful and statistically significant results patients with type 2 and type 3 SMA. 0 MIN READ 02.6.2020
Allakos IPO Expected Next Week for Antibody Immunotherapy Programs Targeting receptors on eosinophils and mast cells to inhibit disease. 3 MIN READ 07.13.2018
Shipping Bottlenecks Could Last Well Into 2022 — Why That’s Good News For Investors